Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nelson Harvey Halpern Insider Profile
4 Followers
Nelson Harvey Halpern, Chief Financial Officer at InnoCan Pharma, holds 360.33K shares in InnoCan Pharma (Ticker: INNPF).
Nelson Harvey Halpern has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Nelson Harvey Halpern's holdings
Insider Roles
Chief Financial Officer
Roles that Nelson Harvey Halpern holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Nelson Harvey Halpern
Nelson Harvey Halpern's Trading History
List of latest transactions for each holding click on a transaction to see Nelson Harvey Halpern's performance on stock
You May Also Like
Nelson Harvey Halpern insider profile FAQ
What is the percentage of profitable transactions made by Nelson Harvey Halpern?
The percentage of profitable transactions made by Nelson Harvey Halpern is ―.
What is the average return per transaction made by Nelson Harvey Halpern?
The average return per transaction made by Nelson Harvey Halpern is ―.
What stocks does Nelson Harvey Halpern hold?
Nelson Harvey Halpern holds: INNPF stocks.
What was Nelson Harvey Halpern’s latest transaction?
Nelson Harvey Halpern latest transaction was an Uninformative Sell of ―.
What was Nelson Harvey Halpern's most profitable transaction?
Nelson Harvey Halpern’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Nelson Harvey Halpern's role in InnoCan Pharma?
Nelson Harvey Halpern's role in InnoCan Pharma is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.